{"id":"ferric-carboxymaltose-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Hypophosphatemia"},{"rate":null,"effect":"Abdominal pain"}]},"_chembl":{"chemblId":"CHEMBL2108597","moleculeType":"Unknown"},"_dailymed":{"setId":"517b4a19-45b3-4286-9f6a-ced4e10447de","title":"INJECTAFER (FERRIC CARBOXYMALTOSE INJECTION) INJECTION, SOLUTION INJECTAFER (FERRIC CARBOXYMALTOSE) INJECTION, SOLUTION [AMERICAN REGENT, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ferric carboxymaltose is an iron replacement therapy consisting of ferric iron complexed with carboxymaltose, a carbohydrate polymer. The complex protects iron from premature release while allowing controlled uptake by transferrin and other iron-binding proteins in the body. This restores iron stores in patients with iron deficiency and enables the bone marrow to produce adequate hemoglobin and red blood cells.","oneSentence":"Ferric carboxymaltose delivers iron as a stable complex that is taken up by iron-binding proteins to replenish depleted iron stores and restore hemoglobin synthesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:21:52.275Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Iron deficiency anemia in adults"},{"name":"Iron deficiency anemia in patients with chronic kidney disease"},{"name":"Iron deficiency anemia in patients intolerant to or with inadequate response to oral iron"}]},"trialDetails":[{"nctId":"NCT07476859","phase":"PHASE4","title":"Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome","status":"RECRUITING","sponsor":"Fundación para la Investigación del Hospital Clínico de Valencia","startDate":"2026-03-05","conditions":"Acute Coronary Syndromes (ACS), Iron Deficiencies, Elderly (People Aged 65 or More)","enrollment":538},{"nctId":"NCT07115121","phase":"NA","title":"Comparison of the Mean Change in Hemoglobin With Ferric Carboxymaltose and IV Iron Sucrose in Anemic Antenatal Patients","status":"COMPLETED","sponsor":"Muhammad Aamir Latif","startDate":"2025-02-02","conditions":"Anemia","enrollment":40},{"nctId":"NCT06994065","phase":"NA","title":"Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients","status":"RECRUITING","sponsor":"Sindh Institute of Urology and Transplantation","startDate":"2025-06-02","conditions":"Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease","enrollment":128},{"nctId":"NCT06895993","phase":"PHASE1","title":"Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants","status":"COMPLETED","sponsor":"Sichuan Huiyu Pharmaceutical Co., Ltd","startDate":"2025-04-07","conditions":"Healthy Adult","enrollment":84},{"nctId":"NCT05816265","phase":"PHASE4","title":"Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure","status":"ENROLLING_BY_INVITATION","sponsor":"Radha Gopalan","startDate":"2024-01-24","conditions":"Heart Failure, Iron-deficiency","enrollment":40},{"nctId":"NCT04343170","phase":"NA","title":"Effect of Ultra-short-term Treatment of Patients With Iron Deficiency or Anemia Undergoing Adolescent Scoliosis Correction","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-09-01","conditions":"Ultra-short-term, Iron Deficiency Anemia, Scoliosis Idiopathic","enrollment":44},{"nctId":"NCT06911034","phase":"PHASE4","title":"Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women","status":"COMPLETED","sponsor":"CMH Multan Institute of Medical Sciences","startDate":"2024-02-01","conditions":"Iron Deficiency Anemia (IDA), Pregnancy","enrollment":60},{"nctId":"NCT06442111","phase":"NA","title":"The Role of Intravenous Ferritin in Optimizing Postoperative Recovery Following Pancreaticoduodenectomy","status":"NOT_YET_RECRUITING","sponsor":"Seoul St. Mary's Hospital","startDate":"2024-07-01","conditions":"Pancreaticojuodenectomy","enrollment":106},{"nctId":"NCT03074591","phase":"PHASE4","title":"Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2017-08-01","conditions":"Iron-deficiency, Heart Failure","enrollment":40},{"nctId":"NCT06080555","phase":"PHASE1","title":"Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia","status":"COMPLETED","sponsor":"Sichuan Huiyu Pharmaceutical Co., Ltd","startDate":"2023-10-09","conditions":"Iron Deficiency, Anaemia","enrollment":84},{"nctId":"NCT06061393","phase":"PHASE4","title":"Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia","status":"UNKNOWN","sponsor":"Western Galilee Hospital-Nahariya","startDate":"2023-10-30","conditions":"Anemia, Iron Deficiency, Pregnancy Anemia","enrollment":200},{"nctId":"NCT02694978","phase":"PHASE3","title":"A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)","status":"COMPLETED","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2016-02-29","conditions":"Iron Deficiency Anemia","enrollment":2014},{"nctId":"NCT03218384","phase":"PHASE2","title":"Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"2017-09-07","conditions":"Iron-deficiency","enrollment":20},{"nctId":"NCT04355130","phase":"","title":"Autologous Tansfusion REquirements in Bone MArrow Harvest: The ATREMA Study","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2020-03-20","conditions":"Bone Marrow Donors","enrollment":7},{"nctId":"NCT05708170","phase":"PHASE4","title":"Impact of Intravenous Iron on Musculoskeletal Function in Older Adults","status":"NOT_YET_RECRUITING","sponsor":"Liverpool Hope University","startDate":"2023-01","conditions":"Iron Deficiency Anemia","enrollment":100},{"nctId":"NCT04083755","phase":"PHASE4","title":"Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With LEAD (IRONPAD)","status":"UNKNOWN","sponsor":"Biobizkaia Health Research Institute","startDate":"2019-08-15","conditions":"Anemia, Peripheral Arterial Occlusive Disease","enrollment":240},{"nctId":"NCT04141631","phase":"NA","title":"Transfusion Savings in Heart Surgery: Impact of Individual Strategy by Erythropoietin and Metabolic Adjustment (ScvO2)","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2020-01-13","conditions":"Cardiac Surgery, Transfusion, Perioperative Anemia","enrollment":128},{"nctId":"NCT05505006","phase":"PHASE4","title":"Management of Preoperative Anaemia in Surgical Oncology","status":"UNKNOWN","sponsor":"Azienda Ospedaliera Universitaria Integrata Verona","startDate":"2021-03-02","conditions":"Anemia, Tumor","enrollment":500},{"nctId":"NCT05477498","phase":"PHASE4","title":"Iron Substitution With Ferric Carboxymaltose as Treatment Strategy for Heart Failure Patients With Preserved Ejection Fraction","status":"WITHDRAWN","sponsor":"Cantonal Hosptal, Baselland","startDate":"2021-12-01","conditions":"Heart Failure With Normal Ejection Fraction, Iron-deficiency","enrollment":""},{"nctId":"NCT04862715","phase":"PHASE4","title":"The Iron and Muscle Study","status":"COMPLETED","sponsor":"King's College Hospital NHS Trust","startDate":"2019-04-26","conditions":"CKD Stage 3, CKD Stage 4, Iron-deficiency","enrollment":75},{"nctId":"NCT00520780","phase":"PHASE3","title":"Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)","status":"COMPLETED","sponsor":"Vifor Pharma","startDate":"2007-04","conditions":"Chronic Heart Failure, Iron Deficiency, Iron Deficiency Anemia","enrollment":456},{"nctId":"NCT02937454","phase":"PHASE4","title":"Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency","status":"COMPLETED","sponsor":"Vifor (International) Inc.","startDate":"2017-04-03","conditions":"Iron Deficiency, Heart Failure","enrollment":1132},{"nctId":"NCT03591406","phase":"PHASE3","title":"To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia","status":"COMPLETED","sponsor":"Vifor (International) Inc.","startDate":"2017-07-03","conditions":"Iron Deficiency Anemia","enrollment":371},{"nctId":"NCT04898569","phase":"PHASE4","title":"Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response and Transfusion in Patients With Iron Deficiency Anemia After Off-Pump Coronary Artery Bypass Grafting","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2019-02-10","conditions":"Coronary Artery Disease","enrollment":100},{"nctId":"NCT02453334","phase":"PHASE3","title":"Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2015-05-23","conditions":"Cancer and Chemotherapy Related Anemia","enrollment":244},{"nctId":"NCT04627181","phase":"PHASE4","title":"Do Iron And Vitamin B12 Injections Given Together, Improve Hemoglobin In Patients On Hemodialysis?","status":"UNKNOWN","sponsor":"Christian Medical College, Vellore, India","startDate":"2020-11-18","conditions":"Iron Deficiency Anemia, B12 Deficiency Anemia","enrollment":100},{"nctId":"NCT02905539","phase":"PHASE4","title":"A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer","status":"COMPLETED","sponsor":"Universität des Saarlandes","startDate":"2016-07","conditions":"Anemia, Iron-Deficiency","enrollment":26},{"nctId":"NCT04616092","phase":"PHASE4","title":"Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2020-11","conditions":"Cerebral Aneurysm Unruptured, Iron Deficiency Anemia, Surgery","enrollment":130},{"nctId":"NCT04510870","phase":"PHASE4","title":"Iron Deficiency as an Ignored Cause of Infertility","status":"UNKNOWN","sponsor":"Dextra Fertility Clinic","startDate":"2020-08-17","conditions":"Iron Deficiency, Infertility","enrollment":62},{"nctId":"NCT02628860","phase":"PHASE2","title":"Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy","status":"COMPLETED","sponsor":"National Cancer Center, Korea","startDate":"2014-01","conditions":"Pancreatic Cancer, Anemia","enrollment":40},{"nctId":"NCT02949947","phase":"PHASE2","title":"Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-12-18","conditions":"Malignant Neoplasms of Mesothelial and Soft Tissue, Gastrointestinal Stromal Tumor With Neurogenic Differentiation","enrollment":3},{"nctId":"NCT03191201","phase":"PHASE4","title":"A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis.","status":"TERMINATED","sponsor":"Prof Gérard WAEBER","startDate":"2017-06-21","conditions":"Iron-deficiency, Iron Toxicity, Glucose Metabolism Disorders (Including Diabetes Mellitus)","enrollment":32},{"nctId":"NCT04187716","phase":"PHASE3","title":"Intravenous Iron Injection in Cancer Patients With Anemia","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2020-02-01","conditions":"Cancer Anaemia","enrollment":341},{"nctId":"NCT03398681","phase":"PHASE4","title":"Changes in Myocardial Iron After Iron Administration","status":"COMPLETED","sponsor":"Fundación para la Investigación del Hospital Clínico de Valencia","startDate":"2017-05-01","conditions":"Heart Failure, Iron-deficiency","enrollment":53},{"nctId":"NCT02496377","phase":"NA","title":"Cross Iron (Comparative Randomized Oral Versus Systemic IRON)","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2014-08-29","conditions":"Allogenic Transfusion, Perioperative Anaemia, Knee Arthroplasty","enrollment":100},{"nctId":"NCT02271997","phase":"PHASE4","title":"Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass","status":"COMPLETED","sponsor":"Rijnstate Hospital","startDate":"2014-12-04","conditions":"Iron Deficiency","enrollment":120},{"nctId":"NCT03707249","phase":"NA","title":"Iron Status and Cardiopulmonary Physiology","status":"COMPLETED","sponsor":"Royal Centre for Defence Medicine","startDate":"2016-01-19","conditions":"Iron-deficiency, Ventricular Function, Pulmonary Vascular Resistance Abnormality","enrollment":18},{"nctId":"NCT03625661","phase":"NA","title":"Impact and Evaluation of the Management of Iron Deficiency With or Without Anemia in Patients With Cancer","status":"COMPLETED","sponsor":"Institut Cancerologie de l'Ouest","startDate":"2014-02-02","conditions":"Iron Deficiency Anemia","enrollment":257},{"nctId":"NCT03561480","phase":"PHASE4","title":"Effect of Postoperative Ferric Carboxymaltose","status":"UNKNOWN","sponsor":"The Catholic University of Korea","startDate":"2018-06-11","conditions":"Postoperative Anemia, Knee Osteoarthritis, Total Knee Arthroplasty","enrollment":80},{"nctId":"NCT03561506","phase":"PHASE4","title":"Effect of Preoperative Ferric Carboxymaltose After Simultaneous Bilateral Total Knee Arthroplasty","status":"UNKNOWN","sponsor":"The Catholic University of Korea","startDate":"2018-06-11","conditions":"Postoperative Anemia, Knee Osteoarthritis, Total Knee Arthroplasty","enrollment":80},{"nctId":"NCT01307007","phase":"PHASE2","title":"Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2010-09","conditions":"Iron Deficiency Anemia","enrollment":69},{"nctId":"NCT03079518","phase":"PHASE2","title":"Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency","status":"COMPLETED","sponsor":"RWTH Aachen University","startDate":"2017-03-10","conditions":"Heart Failure, Systolic, Iron Deficiency","enrollment":23},{"nctId":"NCT02125344","phase":"PHASE3","title":"A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)","status":"COMPLETED","sponsor":"GBG Forschungs GmbH","startDate":"2014-12","conditions":"Tubular Breast Cancer Stage II, Tubular Breast Cancer Stage III, Mucinous Breast Cancer Stage II","enrollment":961},{"nctId":"NCT03050424","phase":"PHASE2","title":"Iron and Chronic Obstructive Pulmonary Disease (COPD) Exercise Trial","status":"UNKNOWN","sponsor":"Royal Brompton & Harefield NHS Foundation Trust","startDate":"2017-04-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":40},{"nctId":"NCT01922479","phase":"PHASE4","title":"Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure","status":"COMPLETED","sponsor":"National University Hospital, Singapore","startDate":"2013-09","conditions":"Heart Failure, Anemia, Iron Deficiency","enrollment":50},{"nctId":"NCT02599012","phase":"PHASE2","title":"The Efficacy of Intravenous Iron for the Treatment of Anemia in Cancer Patients","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2015-09-12","conditions":"Cancer, Anemia","enrollment":100},{"nctId":"NCT03014921","phase":"NA","title":"Impact of Iron Injection on Blood Donation","status":"UNKNOWN","sponsor":"Nicolas Leuenberger","startDate":"2016-12","conditions":"Iron Deficiency","enrollment":19},{"nctId":"NCT01725789","phase":"PHASE3","title":"Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia (FAIRY)","status":"COMPLETED","sponsor":"National Cancer Center, Korea","startDate":"2012-11","conditions":"Anemia","enrollment":454},{"nctId":"NCT02416778","phase":"PHASE4","title":"Effect of Intravenous Iron (Ferinject®) on Exercise Capacity and Quality of Life of Stable COPD Patients","status":"UNKNOWN","sponsor":"Georg-Christian Funk","startDate":"2015-02","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":20},{"nctId":"NCT01154491","phase":"PHASE3","title":"Efficacy of Ferric Carboxymaltose With or Without EPO Reducing Red-cell Transfusion Packs in Hip Fracture Perioperative Period","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2010-06","conditions":"Hip Fractures","enrollment":303},{"nctId":"NCT00821717","phase":"PHASE3","title":"EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure","status":"TERMINATED","sponsor":"Vifor Pharma","startDate":"2008-12","conditions":"Chronic Heart Failure, Iron Deficiency, Iron Deficiency Anemia","enrollment":35},{"nctId":"NCT00810030","phase":"PHASE3","title":"FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR","status":"COMPLETED","sponsor":"Vifor Pharma","startDate":"2008-10","conditions":"Inflammatory Bowel Disease, Anemia, Iron Deficiency","enrollment":484},{"nctId":"NCT01110356","phase":"PHASE4","title":"Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age","status":"COMPLETED","sponsor":"Vifor Pharma","startDate":"2010-06","conditions":"Iron Deficiency","enrollment":294}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"ABDOMINAL PAIN"},{"count":2,"reaction":"BLOOD PRESSURE DECREASED"},{"count":2,"reaction":"FATIGUE"},{"count":2,"reaction":"HAEMOGLOBIN DECREASED"},{"count":2,"reaction":"HYPERSENSITIVITY"},{"count":2,"reaction":"NAUSEA"},{"count":2,"reaction":"VOMITING"},{"count":1,"reaction":"ABORTION INFECTED"},{"count":1,"reaction":"ALANINE AMINOTRANSFERASE INCREASED"},{"count":1,"reaction":"ANAPHYLACTIC REACTION"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ferinject","i.v. iron"],"phase":"marketed","status":"active","brandName":"Ferric Carboxymaltose Injection","genericName":"Ferric Carboxymaltose Injection","companyName":"Sichuan Huiyu Pharmaceutical Co., Ltd","companyId":"sichuan-huiyu-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ferric carboxymaltose delivers iron as a stable complex that is taken up by iron-binding proteins to replenish depleted iron stores and restore hemoglobin synthesis. Used for Iron deficiency anemia in adults, Iron deficiency anemia in patients with chronic kidney disease, Iron deficiency anemia in patients intolerant to or with inadequate response to oral iron.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}